SCHEMBL5428700

SCHEMBL5428700

CCn1c(-c2ccc(Cl)cc2)nc2c(=O)[nH]cnc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.45
ADORA2B P29275 3/20 0.45
ADORA3 P0DMS8 1/20 0.45
ADORA1 P30542 1/20 0.45
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.44
LMNA P02545 1/20 0.43
GFER P55789 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
NPC1 O15118 1/20 0.43
PDE4A P27815 3/20 0.41
PDE4B Q07343 3/20 0.41
PDE4C Q08493 3/20 0.41
PDE4D Q08499 3/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5438910 0.90 NPC1 (0.52) ADORA2AADORA2BADORA3ADORA1KDM4E
SCHEMBL5434848 0.85 ALDH1A1 (0.47) ADORA2AADORA2BADORA3ADORA1KDM4E
SCHEMBL5432006 0.83 POLB (0.39) KDM4EALDH1A1PKMHPGDAPOBEC3G
SCHEMBL5429656 0.83 MEN1 (0.51) ADORA2AADORA2BADORA3ADORA1KDM4E
SCHEMBL5769313 0.81 ALDH1A1 (0.47) ADORA2AADORA2BADORA3ADORA1KDM4E
SCHEMBL5429558 0.80 MEN1 (0.40) ADORA2BALDH1A1NPC1MEN1KMT2A
SCHEMBL4772661 0.76 ALDH1A1 (0.44) ADORA2AADORA2BADORA3ADORA1KDM4E
SCHEMBL5438382 0.76 ALDH1A1 (0.39) ADORA2AADORA3ADORA1ALDH1A1HPGD
SCHEMBL4777008 0.76 ALDH1A1 (0.43) ADORA2AADORA2BADORA3ADORA1KDM4E
SCHEMBL5768787 0.74 ALDH1A1 (0.47) KDM4EALDH1A1PKMHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135454-A1 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) BAYLISS TRACY 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135454-A1 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) TRPV1, TRPV2, TRPV4 ADORA2A 536/4885ADORA2B 556/4885ADORA3 461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.